8,11,14-Eicosatrienoic Acid
"8,11,14-Eicosatrienoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.
| Descriptor ID |
D015126
|
| MeSH Number(s) |
D10.251.355.255.207
|
| Concept/Terms |
8,11,14-Eicosatrienoic Acid- 8,11,14-Eicosatrienoic Acid
- Dihomo-gamma-Linolenic Acid
- Acid, Dihomo-gamma-Linolenic
- Dihomo gamma Linolenic Acid
- Dihomogammalinolenic Acid
- Acid, Dihomogammalinolenic
- 8,11,14 Eicosatrienoic Acid
- DHLA
Homo-gamma Linolenic Acid- Homo-gamma Linolenic Acid
- Acid, Homo-gamma Linolenic
- Homo gamma Linolenic Acid
- Linolenic Acid, Homo-gamma
|
Below are MeSH descriptors whose meaning is more general than "8,11,14-Eicosatrienoic Acid".
Below are MeSH descriptors whose meaning is more specific than "8,11,14-Eicosatrienoic Acid".
This graph shows the total number of publications written about "8,11,14-Eicosatrienoic Acid" by people in this website by year, and whether "8,11,14-Eicosatrienoic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "8,11,14-Eicosatrienoic Acid" by people in Profiles.
-
Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-?-linolenic acid peroxidation dependent mechanism. BMC Cancer. 2018 03 27; 18(1):330.
-
Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain. ACS Chem Neurosci. 2015 Mar 18; 6(3):494-504.
-
Nutritional immunomodulation in critically ill children with acute lung injury: feasibility and impact on circulating biomarkers. Pediatr Crit Care Med. 2013 Jan; 14(1):e45-56.
-
The impact of FADS genetic variants on ?6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet. 2011 May 20; 12:50.
-
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics. 2008 Nov; 18(11):943-53.
-
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation. 2004 Oct 12; 110(15):2132-6.
-
11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. Bioorg Med Chem Lett. 2003 Nov 17; 13(22):4011-4.
-
Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation. 2003 Feb 11; 107(5):769-76.
-
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 2002 May 17; 90(9):1020-7.
-
Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem. 2001 May 11; 276(19):15983-9.